ArticleAmerican journal of translational research2026
LINC00460 drives clear cell renal cell carcinoma progression via complement/coagulation and p53 pathways: a potential therapeutic target.
Bo Dong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.